Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Halbert

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cancer Chemotherapy and Pharmacology|February 22, 2002
A study of amsalog (CI-921) administered orally on a 5-day schedule, with bioavailability and pharmacokinetically guided dose escalationD Fyfe, F Raynaud, R E Langley, et al.
British Journal of Cancer|March 27, 2001
A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphomaF H Blackhall, M Ranson, J A Radford, et al.
Research in Veterinary Science|February 18, 2006
Development of an indirect enzyme-linked immunosorbent assay for detecting equine serum antibodies to the lipopolysaccharide of Salmonella abortusequiD Gall, K Nielsen, R M Bermudez, et al.
British Journal of Cancer|February 23, 2012
The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladderT Qayyum, G Fyffe, M Duncan, et al.
Veterinary Immunology and Immunopathology|September 6, 2008
Validation of a second generation competitive enzyme immunoassay (CELISA) for the diagnosis of brucellosis in various species of domestic animalsK Nielsen, P Smith, W L Yu, et al.
British Journal of Cancer|March 31, 2005
Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcomaK Pritchard-Jones, I Spendlove, C Wilton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2011
Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1S J Danson, P Johnson, T H Ward, et al.
Journal of Immunoassay & Immunochemistry|May 28, 2004
Rough lipopolysaccharide of Brucella abortus RB51 as a common antigen for serological detection of B. ovis, B. canis, and B. abortus RB51 exposure using indirect enzyme immunoassay and fluorescence polarization assayK Nielsen, P Smith, S Conde, et al.
British Journal of Cancer|November 26, 2009
A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopyC P Lee, G S Payne, A Oregioni, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 19, 2009
A cancer research UK pharmacokinetic study of BPA-mannitol in patients with high grade glioma to optimise uptake parameters for clinical trials of BNCTG S Cruickshank, D Ngoga, A Detta, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer Chemotherapy and Pharmacology|February 22, 2002
A study of amsalog (CI-921) administered orally on a 5-day schedule, with bioavailability and pharmacokinetically guided dose escalationD Fyfe, F Raynaud, R E Langley, et al.
British Journal of Cancer|March 27, 2001
A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphomaF H Blackhall, M Ranson, J A Radford, et al.
Research in Veterinary Science|February 18, 2006
Development of an indirect enzyme-linked immunosorbent assay for detecting equine serum antibodies to the lipopolysaccharide of Salmonella abortusequiD Gall, K Nielsen, R M Bermudez, et al.
British Journal of Cancer|February 23, 2012
The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladderT Qayyum, G Fyffe, M Duncan, et al.
Veterinary Immunology and Immunopathology|September 6, 2008
Validation of a second generation competitive enzyme immunoassay (CELISA) for the diagnosis of brucellosis in various species of domestic animalsK Nielsen, P Smith, W L Yu, et al.
British Journal of Cancer|March 31, 2005
Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcomaK Pritchard-Jones, I Spendlove, C Wilton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2011
Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1S J Danson, P Johnson, T H Ward, et al.
Journal of Immunoassay & Immunochemistry|May 28, 2004
Rough lipopolysaccharide of Brucella abortus RB51 as a common antigen for serological detection of B. ovis, B. canis, and B. abortus RB51 exposure using indirect enzyme immunoassay and fluorescence polarization assayK Nielsen, P Smith, S Conde, et al.
British Journal of Cancer|November 26, 2009
A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopyC P Lee, G S Payne, A Oregioni, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|May 19, 2009
A cancer research UK pharmacokinetic study of BPA-mannitol in patients with high grade glioma to optimise uptake parameters for clinical trials of BNCTG S Cruickshank, D Ngoga, A Detta, et al.
Pageof 2